Search Results - "Henkenberens, C."

The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases by Klement, Rainer J, Abbasi-Senger, N, Adebahr, S, Alheid, H, Allgaeuer, M, Becker, G, Blanck, O, Boda-Heggemann, J, Brunner, T, Duma, M, Eble, M J, Ernst, I, Gerum, S, Habermehl, D, Hass, P, Henkenberens, C, Hildebrandt, G, Imhoff, D, Kahl, H, Klass, N D, Krempien, R, Lewitzki, V, Lohaus, F, Ostheimer, C, Papachristofilou, A, Petersen, C, Rieber, J, Schneider, T, Schrade, E, Semrau, R, Wachter, S, Wittig, A, Guckenberger, M, Andratschke, N

“…The aim of this analysis was to model the effect of local control (LC) on overall survival (OS) in patients treated with stereotactic body radiotherapy (SBRT)…”
Get full text

Local recurrence of breast cancer: conventionally fractionated partial external beam re-irradiation with curative intention by Janssen, S., Rades, D., Meyer, A., Fahlbusch, F. B., Wildfang, I., Meier, A., Schild, S., Christiansen, H., Henkenberens, C.

“…Purpose To assess the outcome of breast cancer patients with local recurrence who underwent partial external beam re-irradiation (re-RT) either as part of…”
Get full text

Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy by Klement, R.J., Hoerner-Rieber, J., Adebahr, S., Andratschke, N., Blanck, O., Boda-Heggemann, J., Duma, M., Eble, M.J., Eich, H.C., Flentje, M., Gerum, S., Hass, P., Henkenberens, C., Hildebrandt, G., Imhoff, D., Kahl, K.H., Klass, N.D., Krempien, R., Lohaus, F., Petersen, C., Schrade, E., Wendt, T.G., Wittig, A., Guckenberger, M.

“…Stereotactic body radiotherapy (SBRT) for oligometastatic disease is characterized by an excellent safety profile; however, experiences are mostly based on…”
Get full text

Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease by Tanadini-Lang, S, Rieber, J, Filippi, A.R, Fode, M.M, Streblow, J, Adebahr, S, Andratschke, N, Blanck, O, Boda-Heggemann, J, Duma, M, Eble, M.J, Ernst, I, Flentje, M, Gerum, S, Hass, P, Henkenberens, C, Hildebrandt, G, Imhoff, D, Kahl, H, Klass, N.D, Krempien, R, Lohaus, F, Petersen, C, Schrade, E, Wendt, T.G, Wittig, A, Høyer, M, Ricardi, U, Sterzing, F, Guckenberger, M

“…Abstract Background Radical local treatment of pulmonary metastases is practiced with increasing frequency due to acknowledgment and better understanding of…”
Get full text

Dosimetric Comparison Between Helical Tomotherapy and Volumetric Modulated Arc Therapy in Patients With Malignant Pleural Mesothelioma by Müdder, T., Sarria, G.R., Henkenberens, C., Holz, J., Garbe, S., Röhner, F., Stumpf, S., Buchstab, T., Giordano, F.A., Leitzen, C.

“…To carry out a dosimetric comparison and constraints feasibility proof of adjuvant radiotherapy through helical tomotherapy or volumetric modulated arc therapy…”
Get full text

Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study by Schmidt-Hegemann, N.-S., Kroeze, S.G.C., Henkenberens, C., Vogel, M.M.E., Kirste, S., Becker, J., Burger, I. A., Derlin, T., Bartenstein, P., Eiber, M., Mix, M., la Fougère, Ch, Müller, A.C., Grosu, A.L., Combs, S.E., Christiansen, H., Guckenberger, M., Belka, C.

“…Purpose Approximately 40–70% of biochemically persistent or recurrent prostate cancer (PCa) patients after radical prostatectomy (RPE) are oligo-metastatic in…”
Get full text

Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose by Wilke, L., Moustakis, C., Blanck, O., Albers, D., Albrecht, C., Avcu, Y., Boucenna, R., Buchauer, K., Etzelstorfer, T., Henkenberens, C., Jeller, D., Jurianz, K., Kornhuber, C., Kretschmer, M., Lotze, S., Meier, K., Pemler, P., Riegler, A., Röser, A., Schmidhalter, D., Spruijt, K. H., Surber, G., Vallet, V., Wiehle, R., Willner, J., Winkler, P., Wittig, A., Guckenberger, M., Tanadini-Lang, S.

“…Purpose Dose, fractionation, normalization and the dose profile inside the target volume vary substantially in pulmonary stereotactic body radiotherapy (SBRT)…”
Get full text

Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience by Henkenberens, C, Janssen, S, Lavae-Mokhtari, M, Leni, K, Meyer, A, Christiansen, H, Bremer, M, Dickgreber, N

“…To assess efficacy of our single-centre experience with inhalative steroids (IS) in lung cancer patients with symptomatic radiation pneumonitis (RP) grade II…”
Get full text

Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer—results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group by Ostheimer, C., Mäurer, M., Ebert, N., Schmitt, D., Krug, D., Baumann, R., Henkenberens, C., Giordano, F. A., Sautter, L., López, Guerra, Fleischmann, D. F., Niyazi, M., Käsmann, L., Kaul, D., Thieme, A. H., Billiet, C., Dobiasch, S., Arnold, C. R., Oertel, M., Haussmann, J., Gauer, T., Goy, Y., Suess, C., Ziegler, S., Panje, C. M., Baues, C., Trommer, M., Skripcak, T., Medenwald, D.

“…Background In radical radiochemotherapy (RCT) of inoperable non-small-cell lung cancer (NSCLC) typical prognostic factors include T- and N-stage, while there…”
Get full text

Correction to: Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer—results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group by Ostheimer, C., Mäurer, M., Ebert, N., Schmitt, D., Krug, D., Baumann, R., Henkenberens, C., Giordano, F. A., Sautter, L., López, Guerra, Fleischmann, D. F., Niyazi, M., Käsmann, L., Kaul, D., Thieme, A. H., Billiet, C., Dobiasch, S., Arnold, C. R., Oertel, M., Haussmann, J., Gauer, T., Goy, Y., Suess, C., Ziegler, S., Panje, C. M., Baues, C., Trommer, M., Skripcak, T., Medenwald, D.

“…A Correction to this paper has been published: https://doi.org/10.1007/s00066-020-01727-4…”
Get full text

A new era of thoracic oncology? Ex-vivo stereotactic ablative radiosurgery within Ex-vivo Lung Treatment System as a hybrid therapy for unresectable locally advanced pulmonary malignancies by Henkenberens, C, Zinne, N, Biancosino, C, Höffler, K, Schmitto, J.D, Bremer, M, Haverich, A, Krüger, M

“…Abstract The concept of oligometastases is the medical rationale for a local treatment of a limited number of metastatic tumor manifestations. Patients with…”
Get full text

SBRT for Lung Metastases: A Pooled Analysis of 651 Patients and 868 Lesions of the German Working Group Stereotactic Radiotherapy by Sterzing, F, Streblow, J, Scherer, K, Adebahr, S, Adratschke, N, Boda-Heggemann, J, Blanck, O, Duma, M, Ernst, I, Gademann, G, Ganswindt, U, Henkenberens, C, Imhoff, D, Kahl, H, Lohaus, F, Lubinski-de Lange, G, Maertin, A, Petersen, C, Wittig, A, Guckenberger, M

Get full text

Kleinzelliges Lungenkarzinom by Steins, M. B., Henkenberens, C., Bremer, M., Thomas, M.

“…Zusammenfassung Hintergrund Prognostische Verbesserungen für Patienten mit einem kleinzelligen Lungenkarzinom (SCLC) konnten in der letzten Dekade insbesondere…”
Get full text

Plastische Rekonstruktion von Strahlenfolgen by Vogt, P. M., Mett, T. R., Henkenberens, C., Radtke, C., Ipaktchi, R.

“…Zusammenfassung Die Bestrahlung der Tumorregion stellt neben der medikamentösen und chirurgischen Therapie die dritte Säule der modernen Onkologie dar. Sie…”
Get full text

Plastic reconstruction of radiation injuries by Vogt, P M, Mett, T R, Henkenberens, C, Radtke, C, Ipaktchi, R

“…In addition to surgical and drug therapy, radiotherapy (or radiation therapy) is one of the three mainstays of modern oncological therapy regimes. It uses…”
Get full text

Early Efficacy of 68ga-PSMA Ligand Positron Emission Tomography/Computed Tomography–Based Radiation Treatment in Locally Recurrent and Oligometastatic Prostate Cancer After Primary Therapy by Henkenberens, C., Bengel, F., Wester, H.J., Christiansen, H., Derlin, T.

Get full text

Early Efficacy of68ga-PSMA Ligand Positron Emission Tomography/Computed Tomography–Based Radiation Treatment in Locally Recurrent and Oligometastatic Prostate Cancer After Primary Therapy by Henkenberens, C., Bengel, F., Wester, H.J., Christiansen, H., Derlin, T.

Get full text

Post-Operative Stereotactic Radiotherapy for Resected Brain Metastases: Results of the Multicenter Analysis (AURORA) of the German Working Group "Stereotactic Radiotherapy" by Bernhardt, D., Peeken, J.C., Kehl, V., Eitz, K., Guckenberger, M., Andratschke, N., Mayinger, M.C., Lindel, K., Dieckmann, K., El Shafie, R., Debus, J., Riesterer, O., Rogers, S., Blanck, O., Wolff, R., Grosu, A., Bilger, A., Henkenberens, C., Schulze, K., Gani, C., Müller, A.C., Radlanski, K., Janssen, S., Ferentinos, K., Combs, S.E.

“…While the results of prospective studies support the use of postoperative stereotactic radiotherapy (RT) to the resection cavity (RC) as the standard of care…”
Get full text

Early Efficacy of68 ga-PSMA Ligand Positron Emission Tomography/Computed Tomography–Based Radiation Treatment in Locally Recurrent and Oligometastatic Prostate Cancer After Primary Therapy by Henkenberens, C, Bengel, F, Wester, H.J, Christiansen, H, Derlin, T

Get full text

Long-Term Characterization of MRI-Morphologic Alterations After Active Motion-Compensated Liver SBRT by Sarria, G.R., Dreher, C., Miebach, G., Henkenberens, C., Stera, S., Wojtal, P., Krug, D., Oppitz, H., Giordano, F.A., Schäfer, J.J., Lohr, F., Dunst, J., Blanck, O., Boda-Heggemann, J.

“…To characterize the post-SBRT MRI-morphologic alterations in long-term survivors with MRI-based follow-up (FU) in patients treated by actively motion managed…”
Get full text